BRIDGEBIO PHARMA INC - NOTE 2.500% 3/1

CUSIP: 10806XAB8

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Debt / NOTE 2.500% 3/1
Market price (% of par)
7329.41%
Total 13F principal
$24,428,285
Principal change
-$18,340,750
Total reported market value
$29,769,764
Number of holders
5
Value change
-$9,378,870
Number of buys
2
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 10806XAB8?
CUSIP 10806XAB8 identifies 10806XAB8 - BRIDGEBIO PHARMA INC - NOTE 2.500% 3/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BRIDGEBIO PHARMA INC - NOTE 2.500% 3/1 as of Q1 2023

As of 31 Mar 2023, BRIDGEBIO PHARMA INC - NOTE 2.500% 3/1 was held by 5 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $24,428,285 in principal (par value) of the bond. The largest 5 bondholders included MACKAY SHIELDS LLC, Calamos Advisors LLC, Context Capital Management, LLC, SG Americas Securities, LLC, and FIFTH THIRD BANCORP. This page lists 5 institutional bondholders reporting positions for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.